(Q27653013)
Statements
Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment (English)
0 references
1 January 2009
0 references
19
0 references
1
0 references
62-6
0 references